Orexo: A transformative year

Research Note

2021-01-28

09:14

Redeye lowers somewhat the fair value per share of Orexo to SEK 59 (62). Although we expect revenues to stabilise, the new policy to have a positive impact, digital therapies to pick up and OX124 to show progress, investments will be needed. We would like to see more tangible signals about revenue growth.

GA

Gergana Almquist

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.